These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 2807914)

  • 21. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
    Risser J; Pressley Z; Veledar E; Washington C; Chen SC
    J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple primary (even in situ) melanomas in a patient pose significant risk to family members.
    Chen T; Hemminki K; Kharazmi E; Ji J; Sundquist K; Fallah M
    Eur J Cancer; 2014 Oct; 50(15):2659-67. PubMed ID: 25103454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi.
    Richtig E; Langmann G; Müllner K; Smolle J
    Ophthalmologica; 2004; 218(2):111-4. PubMed ID: 15004500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Miscellaneous genodermatoses: Beckwith-Wiedemann syndrome, Birt-Hogg-Dube syndrome, familial atypical multiple mole melanoma syndrome, hereditary tylosis, incontinentia pigmenti, and supernumerary nipples.
    Cohen PR; Kurzrock R
    Dermatol Clin; 1995 Jan; 13(1):211-29. PubMed ID: 7712645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial cutaneous melanoma.
    Lucchina LC; Barnhill RL; Duke DM; Sober AJ
    Melanoma Res; 1995 Dec; 5(6):413-8. PubMed ID: 8589615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Important risk factors in melanoma from the Dermato-Oncologic Unit of Brescia, Italy.
    Manganoni AM; Zanotti F; Farisoglio C; Feroldi P; Facchetti F; Calzavara-Pinton P
    Dermatol Online J; 2010 Jan; 16(1):17. PubMed ID: 20137759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of Next Melanoma in Patients With Familial and Sporadic Melanoma by Number of Previous Melanomas.
    Chen T; Fallah M; Försti A; Kharazmi E; Sundquist K; Hemminki K
    JAMA Dermatol; 2015 Jun; 151(6):607-15. PubMed ID: 25671687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanoma risk in individuals with clinically atypical nevi.
    Kang S; Barnhill RL; Mihm MC; Fitzpatrick TB; Sober AJ
    Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysplastic nevi in relation to superficial spreading melanoma.
    Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of self-examination in the earliest diagnosis of multiple primary cutaneous melanomas: a report of 47 cases.
    Manganoni AM; Farisoglio C; Tucci G; Facchetti F; Calzavara Pinton PG
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1333-6. PubMed ID: 17958838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant melanoma of skin and eye in the same family: more than a coincidence?
    Van Ruymbeke K; Leys A
    Bull Soc Belge Ophtalmol; 1989; 231():149-55. PubMed ID: 2488447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome.
    Rulyak SJ; Brentnall TA; Lynch HT; Austin MA
    Cancer; 2003 Aug; 98(4):798-804. PubMed ID: 12910525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
    Pho L; Grossman D; Leachman SA
    Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.
    Halpern AC; Guerry D; Elder DE; Clark WH; Synnestvedt M; Norman S; Ayerle R
    Arch Dermatol; 1991 Jul; 127(7):995-9. PubMed ID: 2064418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population-based analysis of prognostic factors and survival in familial melanoma.
    Florell SR; Boucher KM; Garibotti G; Astle J; Kerber R; Mineau G; Wiggins C; Noyes RD; Tsodikov A; Cannon-Albright LA; Zone JJ; Samlowski WE; Leachman SA
    J Clin Oncol; 2005 Oct; 23(28):7168-77. PubMed ID: 16192601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dysplastic nevus syndrome].
    Niebauer G; Kokoschka EM
    Wien Klin Wochenschr; 1986 Oct; 98(20):673-8. PubMed ID: 3788185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
    Fisher NM; Schaffer JV; Berwick M; Bolognia JL
    J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple primary cutaneous melanomas.
    Beardmore GL; Davis NC
    Arch Dermatol; 1975 May; 111(5):603-9. PubMed ID: 1130805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple primary melanomas in a patient with familial-type DNS during clomiphene-induced pregnancy.
    Kuppens E; Bergman W; Welvaart K; Bruijn JA; Scheffer E
    Melanoma Res; 1992 May; 2(1):71-4. PubMed ID: 1643427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dysplastic nevus syndrome of familial type. A family study].
    Grimstvedt MB
    Tidsskr Nor Laegeforen; 1992 Mar; 112(7):869-72. PubMed ID: 1557751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.